Targeting NMNAT1 to axons and synapses transforms its neuroprotective potency in vivo.
Babetto
Elisabetta
E
The Babraham Institute, Laboratory of Molecular Signalling, Cambridge CB22 3AT, UK.
Beirowski
Bogdan
B
Janeckova
Lucie
L
Brown
Rosalind
R
Gilley
Jonathan
J
Thomson
Derek
D
Ribchester
Richard R
RR
Coleman
Michael P
MP